In summary, TRPV4 is a receptor-selective regulator of activated calcium influx in breast cancer cells that overexpress TRPV4 and pharmacological activation of TRPV4 is sufficient to induce EMT in these cells. This evidence concerns the gene TRPV4 and breast cancer.